Evaluating the Role and Policy Implications of Using External Evidence in Survival Extrapolations: A Case Study of Axicabtagene Ciloleucel Therapy for Second-Line DLBCL.
| Publicado en: | PharmacoEconomics Vol. 43; no. 11; pp. 1293 - 1308 |
|---|---|
| Autores principales: | , , , , , , , , |
| Formato: | Journal Article |
| Publicado: |
Springer Nature
Nov2025
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=188778332&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 188778332 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 11707690 C5G jtl: PharmacoEconomics issn: 11707690 maglogo: N pubinfo: dt: Nov2025 vid: 43 iid: 11 pid: 237 pub: Springer Nature place: New York, New York artinfo: ui: 188778332 187181937 10.1007/s40273-025-01529-5 188778332 ppf: 1293 ppct: 15 formats: tig: atl: Evaluating the Role and Policy Implications of Using External Evidence in Survival Extrapolations: A Case Study of Axicabtagene Ciloleucel Therapy for Second-Line DLBCL. aug: au: Harper, Sam Afonso, Daniela Watts, Karina Doble, Brett Eklund, Oskar Vadgama, Sachin Snider, Julia Thornton Palmer, Stephen Taylor, Matthew affil: https://ror.org/04m01e293 York Health Economics Consortium, University of York, Heslington, York, UK sug: pubtype: Academic Journal doctype: Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|